SCHEMBL4147882

SCHEMBL4147882

O=C(CCc1ccc(O)cc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.61
ACE P12821 6/20 0.59
FOLH1 Q04609 1/20 0.57
ITGB3 P05106 1/20 0.56
ITGA2B P08514 1/20 0.56
GRIA1 P42261 1/20 0.55
MME P08473 2/20 0.53
CPA1 P15085 1/20 0.52
ACE2 Q9BYF1 1/20 0.52
HDAC2 Q92769 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
EPHX2 P34913 1/20 0.51
PTPN2 P17706 1/20 0.51
PTPN1 P18031 1/20 0.51
CDC25B P30305 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4147877 1.00 NAALAD2 (0.61) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL4147924 0.96 ITGB3 (0.62) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL4147927 0.96 ITGB3 (0.62) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL4147417 0.96 ITGB3 (0.62) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL4147413 0.96 ITGB3 (0.62) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL30845347 0.93 NAALAD2 (0.54) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL30081063 0.93 ACE (0.56) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL30081065 0.93 ACE (0.56) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL5370187 0.90 NAALAD2 (0.54) NAALAD2ACEFOLH1ITGB3ITGA2B
SCHEMBL7709347 0.90 NAALAD2 (0.54) NAALAD2ACEFOLH1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704757-A1 SEMICRYSTALLINE SULFUR CONTAINING POLYMERS FOR ORTHODONTIC APPLICATIONS Align Technology, Inc. (US) 2026-03-11 EP claimed
US-12558361-B1 Method and composition for treating non-cirrhotic NASH LIPOCINE, INC. 2026-02-24 US claimed
WO-2025226939-A1 ENHANCED SENSATION CONDOM NUCEPTIVE LABS, INC. (US) 2025-10-30 WO claimed
EP-4608465-A1 ENHANCED SENSATION CONDOM Nuceptive Labs, Inc. (US) 2025-09-03 EP claimed
EP-4608466-A1 STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS Nuceptive Labs, Inc. (US) 2025-09-03 EP claimed
EP-3383321-B1 TEGMEN PLATE PROSTHESIS AND METHODS FOR MANUFACTURING THE SAME UNIV MICHIGAN REGENTS (US) 2025-08-27 EP claimed
WO-2025122010-A1 A METHOD FOR PURIFYING A MODIFIED GELATIN SENTRYX B.V. (NL) 2025-06-12 WO claimed
WO-2025073187-A1 SMALL MOLECULES BASED ELECTRODE FOR GREEN METHANE AND TOWN GAS PRODUCTION FROM CARBON DIOXIDE AT HIGH RATES THE CHINESE UNIVERSITY OF HONG KONG (CN) 2025-04-10 WO claimed
CN-119775550-A Soluble single-site ruthenium-based self-contained microporous polymer catalyst and preparation method and application thereof 山东大学 2025-04-08 CN claimed
WO-2024233367-A1 SEMICRYSTALLINE SULFUR CONTAINING POLYMERS FOR ORTHODONTIC APPLICATIONS ALIGN TECHNOLOGY, INC. (US) 2024-11-14 WO claimed
WO-2024092174-A1 STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS NUCEPTIVE LABS, INC. (US) 2024-05-02 WO claimed
WO-2024092168-A1 ENHANCED SENSATION CONDOM NUCEPTIVE LABS, INC. (US) 2024-05-02 WO claimed
CN-117619153-A Preparation method of polyamide composite membrane and application of composite membrane 南开大学 2024-03-01 CN claimed
CN-113416316-B MOFs-zinc material and preparation method and application thereof 福建师范大学 2022-11-15 CN claimed
CN-113322476-B Preparation method and application of silver-doped copper nanosheet catalyst 吉林大学 2022-08-09 CN claimed
CN-102405079-A Products comprising N-phenylpropenoyl amino acid amides and use thereof NESTEC SA 2012-04-04 CN claimed
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) 2009-04-30 US claimed
EP-1876169-A1 PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" (RU) 2008-01-09 EP claimed
WO-2026107487-A1 BIODEGRADABLE POLYMERS AND METHODS OF MAKING SAME YALE UNIVERSITY (US) 2026-05-21 WO disclosed
EP-1876169-A1 PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" (RU) 2008-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof PAH, MAOA, APEH NAALAD2 93/4885ACE 432/4885FOLH1 355/4885
US-12558361-B1 Method and composition for treating non-cirrhotic NASH LIPC, SHBG, MTTP NAALAD2 1889/4885ACE 2076/4885FOLH1 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.